Freeline Therapeutics Holdings Executives
Freeline Therapeutics employs about 152 people. The company is managed by 12 executives with a total tenure of roughly 355 years, averaging almost 29.0 years of service per executive, having 12.67 employees per reported executive. Analysis of Freeline Therapeutics' management performance can provide insight into the firm performance.
Freeline |
Freeline Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.555) % which means that it has lost $0.555 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0126) %, meaning that it created substantial loss on money invested by shareholders. Freeline Therapeutics' management efficiency ratios could be used to measure how well Freeline Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Freeline Therapeutics Workforce Comparison
Freeline Therapeutics Holdings is one of the top stocks in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 259. Freeline Therapeutics totals roughly 152 in number of employees claiming about 59% of equities under Health Care industry.
Freeline Therapeutics Notable Stakeholders
A Freeline Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Freeline Therapeutics often face trade-offs trying to please all of them. Freeline Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Freeline Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael JD | CEO Director | Profile | |
| Amit MD | Independent Founder | Profile | |
| Markus Horer | CTO Founder | Profile | |
| Henning Stennicke | Chief Officer | Profile | |
| Naomi Aoki | Senior Relations | Profile | |
| James Bircher | Chief Officer | Profile | |
| Amy Spandau | Interim Finance | Profile | |
| Pamela MD | Chief Officer | Profile | |
| Arne Naeveke | VP Communications | Profile | |
| Alison MD | Sr Officer | Profile | |
| Nicole SPHR | Chief Officer | Profile | |
| Paul Schneider | Chief Officer | Profile |
Freeline Therapeutics Workforce Analysis
Traditionally, organizations such as Freeline Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Freeline Therapeutics within its industry.Freeline Therapeutics Manpower Efficiency
Return on Freeline Therapeutics Manpower
| Revenue Per Employee | 4.1K | |
| Revenue Per Executive | 51.8K | |
| Net Loss Per Employee | 328.5K | |
| Net Loss Per Executive | 4.2M | |
| Working Capital Per Employee | 241.2K | |
| Working Capital Per Executive | 3.1M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Freeline Stock
If you are still planning to invest in Freeline Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Freeline Therapeutics' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |